Neuroblastoma classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]
Overview
Overview
International neuroblastoma pathology classification system is used for the classification of neuroblastic tumors. It is subdivided in 02 main categories based on the morphologic features of neuroblastic tumors into; schwannian stroma-poor and schwannian stroma-rich/dominant.
Classification
Classification
- International neuroblastoma pathology classification, a system based on the framework of Shimada classification with minor modifications is proposed for international use in classification of neuroblastic tumors. [1][2][3]
- It is a biologically relevant and pathologically significant classification system based on the morphologic features of neuroblastic tumors,i-e,neuroblastoma, ganglioneuroblastoma and ganglioneuroma.[4][5]
Neuroblastic tumors | |||||||||||||||||||||||||||||
| Schwannian stroma-poor group | Schwannian stroma-rich/dominant group | ||||||||||||||||||||||||||||
Undifferentiated neuroblastoma Poorly differentiated neuroblastoma Differentiating neuroblastoma |
Nodular ganglioneuroblastoma Intermixed ganglioneuroblastoma Maturing ganglioneuroma Mature ganglioneuroma | ||||||||||||||||||||||||||||
References
References
- ↑ Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015
- ↑ Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S; et al. (2001). “International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children’s Cancer Group”. Cancer. 92 (9): 2451–61. PMID 11745303.
- ↑ Shimada, Hiroyuki; Ambros, Inge M.; Dehner, Louis P.; Hata, Jun-ichi; Joshi, Vijay V.; Roald, Borghild; Stram, Daniel O.; Gerbing, Robert B.; Lukens, John N.; Matthay, Katherine K.; Castleberry, Robert P. (1999). “The International Neuroblastoma Pathology Classification (the Shimada system)”. Cancer. 86 (2): 364–372. doi:10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7. ISSN 0008-543X.
- ↑ H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi, B. Roald, D. O. Stram, R. B. Gerbing, J. N. Lukens, K. K. Matthay & R. P. Castleberry (1999). “The International Neuroblastoma Pathology Classification (the Shimada system)”. Cancer. 86 (2): 364–372. PMID 10421273. Unknown parameter
|month=ignored (help) - ↑ H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi & B. Roald (1999). “Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee”. Cancer. 86 (2): 349–363. PMID 10421272. Unknown parameter
|month=ignored (help)
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH